Veterans are significantly less likely to seek mental health treatment than civilians with comparable symptom severity — and research points to stigma, not lack of awareness, as the primary driver. The misconceptions that keep veterans from getting effective care are not random; they are predictable, deeply embedded in service culture, and worth addressing directly. At Oasis Therapeutics, we are a veteran-owned practice in Nashua and Concord, New Hampshire, and we have these conversations every day — so this blog addresses the ones we hear most often.
Misconception 1: Seeking Mental Health Treatment Means You Can’t Handle It
This is the most pervasive misconception in service culture, and it causes more preventable suffering than any other. The belief that managing psychological distress without outside help is a mark of competence — and that seeking treatment is evidence of weakness — is so thoroughly baked into military and first responder culture that many veterans carry it long after leaving service.
It is worth being direct: PTSD, depression, and anxiety are not character failures. They are neurobiological conditions with documented physiological mechanisms (Mayo Clinic). PTSD involves measurable changes in brain structure and function — including chronic overactivation of the amygdala (the brain region responsible for processing fear and stress) and disruption of prefrontal cortex regulation — that are not accessible to willpower. Treating them with evidence-based clinical tools is the same category of decision as treating a broken bone or a cardiac condition. The values of service — discipline, commitment, taking care of your people — are entirely consistent with getting effective treatment.
We are a veteran-owned practice. We say that not as a credential but because it changes the nature of the conversation in our clinic. Our founders served. They understand the culture, and they understand why this misconception is so hard to release. That understanding is embedded in how we approach every evaluation. Learn more about our care for veterans and first responders and what makes our approach different.
Misconception 2: Medication Is the Only Option
Many veterans arrive having tried one or more antidepressants or anti-anxiety medications and concluded — often correctly — that those medications did not provide adequate relief. The misconception that follows is that medication is the only available clinical intervention, and therefore that nothing will work.
The treatment options available for trauma-related conditions, depression, and anxiety have expanded considerably in recent years. Transcranial magnetic stimulation (TMS) — a non-invasive procedure that uses magnetic pulses to stimulate targeted brain regions — has received FDA clearance for major depressive disorder and has a strong, peer-reviewed evidence base (National Institutes of Health). It does not involve medication, does not require anesthesia, and does not carry the systemic side effects associated with antidepressants. Many insurance plans cover it, including TRICARE and the Veterans Administration.
Ketamine infusion therapy works through the brain’s glutamate system — a completely different mechanism than conventional antidepressants — and has demonstrated rapid and significant antidepressant effects in patients who have not responded to prior medications (Nature). Stellate ganglion block (SGB) targets the sympathetic nervous system directly through a minimally invasive injection and has shown meaningful reductions in PTSD symptom severity in clinical research including a randomized controlled trial published in JAMA Psychiatry. SPRAVATO® (esketamine nasal spray) is an FDA-approved treatment for treatment-resistant depression and for major depressive disorder with acute suicidal ideation or behavior, available at our certified treatment centers in Nashua and Concord.
None of these are experimental. They are clinically validated, evidence-based treatments that operate through mechanisms distinct from conventional pharmacotherapy. A prior history of medication that did not work is not a reason to stop — it is often the precise qualification for the treatments we offer.
Misconception 3: Treatment Will Require Reliving the Trauma
This misconception is specific to trauma treatment and reflects a real concern — many veterans have heard about exposure-based therapies that involve systematically revisiting traumatic memories and are not willing to go through that process. The concern is legitimate, and it deserves an honest response rather than dismissal.
The treatments we offer at Oasis Therapeutics do not require trauma narration or exposure. Ketamine infusion therapy, TMS, SGB, and SPRAVATO® are all neurobiological interventions that address the physiological underpinnings of trauma-related conditions without requiring a patient to recount or re-experience what happened. The mechanisms are pharmacological and procedural, not narrative.
We do recommend that patients maintain a relationship with a mental health therapist alongside clinical treatment, because the two approaches address different dimensions of the same condition and work better together. But that recommendation is distinct from mandatory trauma exposure. Psychotherapy takes many forms, and evidence-based options exist that do not involve systematic reliving of traumatic events. We discuss this openly with patients who have this concern and help them think through what kind of complementary support would actually work for them. For a deeper look at how TMS and other approaches compare for trauma-related conditions, see our blog post on PTSD treatment with TMS.
Misconception 4: These Treatments Are Only for Severe Cases
Some veterans delay seeking care because they believe clinical intervention is reserved for people who are worse off than they are — that they need to hit a more defined threshold of crisis before treatment is appropriate. This misconception contributes to the pattern in which people arrive at our clinic after years of managing symptoms that, had they been addressed earlier, might have responded more readily to treatment.
Clinical treatment is not a last resort. It is an appropriate option for anyone whose mental health symptoms are significantly affecting their quality of life, their relationships, or their function — regardless of whether they have been formally diagnosed or whether they consider their situation severe enough by some external standard. If you are struggling and what you have tried is not working, that is sufficient reason to have a clinical evaluation.
There is also a practical dimension: treatment-resistant conditions can become more entrenched over time as the nervous system adapts to a chronic stress state. Addressing the problem earlier rather than later is generally in a patient’s interest, not a sign of overreaction. Our PTSD treatment page outlines what an evaluation and care pathway at our clinic looks like, and what conditions we routinely address.
Misconception 5: Innovative Treatments Are Unproven
The language around ketamine, TMS, and SGB — described variously as cutting-edge, emerging, or innovative — can inadvertently suggest that these treatments lack a solid evidence base. That framing is not accurate.
TMS has been FDA-cleared since 2008 and has accumulated over fifteen years of peer-reviewed clinical research (National Institutes of Health). Ketamine has been used as a safe, well-established anesthetic in medical settings for decades (Johns Hopkins Bloomberg School of Public Health), and its antidepressant applications have been studied in rigorous clinical trials. SPRAVATO® is FDA-approved — meaning it passed the full regulatory review process for safety and efficacy. SGB has been studied in randomized controlled trials, including the JAMA Psychiatry study that found significant reductions in PTSD symptom severity compared to a sham procedure.
These treatments are innovative in the sense that they represent newer applications and mechanisms. They are not innovative in the sense of being untested. The evidence base matters, and we discuss it in detail at every consultation because we believe patients deserve to understand what supports the treatments they are considering. Our blog post comparing depression treatments — including ketamine therapy and TMS — walks through the clinical evidence in more detail.
Two Practical Barriers Worth Addressing
“I don’t know how to start or what to ask.” This is more common than most people admit. Walking into a mental health clinic when you are not sure what you need, or what the clinic actually does, requires a degree of vulnerability that service culture trains out of people. We designed our consultation process to be straightforward rather than clinical and intimidating. You do not need to arrive with the right vocabulary or a clear diagnosis. You can arrive with a description of what has not been working and let us take it from there.
Cost and coverage: TMS is covered by many major insurance plans at our clinic, including United Healthcare, Blue Cross Blue Shield, Cigna, Aetna, Medicare, TRICARE, the Veterans Administration, Harvard Pilgrim, and NH Healthy Families. SPRAVATO® is also insurance-covered. For services not covered by your plan, we offer discounted direct-payment rates and financing through CareCredit. HSA and FSA funds are eligible. Our care coordination team handles verification before treatment begins. Results vary by individual, and we encourage every patient to discuss their options with their healthcare provider before making treatment decisions.
Frequently Asked Questions
Will a mental health diagnosis affect my security clearance or military career? This is a concern we hear from active duty service members and veterans in careers with security clearance requirements, and it is one that deserves honest acknowledgment rather than a blanket reassurance. The relationship between mental health treatment and security clearance determinations is nuanced and has evolved over time. We encourage anyone with this specific concern to review current guidance from the relevant authority for their branch or employment situation and to consult with a legal or security professional if needed. What we can say is that untreated mental health conditions carry their own risks in this context, and that seeking treatment is increasingly recognized within the military and security communities as a responsible rather than disqualifying step.
What if I’ve had bad experiences with mental health providers in the past? Prior negative experiences with mental health care — providers who seemed dismissive, treatments that did not help, systems that felt bureaucratic or impersonal — are common among veterans and are a legitimate reason for caution. We cannot speak to those experiences, but we can describe how we operate: thorough evaluations, direct conversations, treatment decisions made collaboratively, and a practice built specifically for people whose conditions have not responded to conventional care.
Do I have to have a PTSD diagnosis to be seen at Oasis Therapeutics? No. We evaluate patients based on their symptoms and history, not on a prior formal diagnosis. Many patients arrive without a current diagnosis or with a diagnosis they are uncertain about. The evaluation process is designed to clarify the clinical picture, not to confirm a label you arrived with.
Key Takeaways
- Seeking mental health treatment is consistent with the values of service — PTSD, depression, and anxiety are neurobiological conditions, not character failures.
- Medication is not the only clinical option. TMS, ketamine infusion therapy, SGB, and SPRAVATO® are all evidence-based, clinically validated treatments available at Oasis Therapeutics.
- Clinical treatment at our clinic does not require trauma narration or exposure. Our treatments are neurobiological interventions that address the physiological roots of trauma-related conditions.
- Treatment is appropriate well before a crisis point — addressing symptoms earlier rather than later is generally in a patient’s interest.
- Cost and coverage are manageable. TMS and SPRAVATO® are insurance-covered at our clinic, and financing and direct-payment options are available for other services.
The misconceptions that keep veterans from getting effective mental health care are understandable given the culture of service — but they are costing people years of preventable suffering. If you are a veteran or first responder in New England who has questions about what treatment options actually exist and whether any of them are right for you, we are here to have that conversation without judgment. Schedule a consultation at our Nashua or Concord clinic, and we will give you honest, direct information about what we offer and what the evidence says. We encourage you to discuss your options with your healthcare provider as you make those decisions.
References
Mayo Clinic. Symptoms of PTSD. https://www.mayoclinic.org/diseases-conditions/post-traumatic-stress-disorder/symptoms-causes/syc-20355967
Nature. Ketamine’s Effectiveness for Depression. https://www.nature.com/articles/s41398-021-01327-5
National Institutes of Health. TMS FDA Approval — General. https://pmc.ncbi.nlm.nih.gov/articles/PMC8864803/
Johns Hopkins Bloomberg School of Public Health. History of Ketamine. https://publichealth.jhu.edu/2024/what-to-know-about-ketamine
JAMA Psychiatry. Effects of Stellate Ganglion Block on PTSD Symptoms. https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2753810
Medical Disclaimer
The information in this blog is for educational purposes only and does not constitute medical advice. The treatments described — including ketamine infusion therapy, transcranial magnetic stimulation, stellate ganglion block, and SPRAVATO® — should only be pursued under the supervision of a licensed provider familiar with your full medical and psychiatric history. Individual results vary. Not all treatments are appropriate for all patients. If you are experiencing a mental health crisis or thoughts of self-harm, please call or text 988 to reach the Suicide and Crisis Lifeline or go to your nearest emergency room.